Clinical Trial Update: Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

View source ↗

Summary

A completed clinical trial evaluated norepinephrine transporter blockade as a pathological biomarker in neurogenic orthostatic hypotension and related autonomic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Orthostatic Hypotension
• Parkinson Disease
• Pure Autonomic Failure

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Orthostatic Hypotension, Pure Autonomic Failure | Status: COMPLETED